AIMS/HYPOTHESIS: Although insulin resistance has been associated with accumulations of specific intramuscular fatty acids and altered subcellular localisation of lipid droplets, these concepts remain controversial. Therefore, we aimed to identify specific intramuscular fatty acids and subcellular lipid localisations associated with improved insulin sensitivity following chronic muscle contraction. METHODS: In lean and insulin-resistant obese Zucker rats the tibialis anterior muscle was stimulated (6 h/day for 6 days). Thereafter, muscles were examined for insulin sensitivity, intramuscular lipid droplet localisation and triacylglycerol (TAG), diacylglycerol (DAG) and ceramide fatty acid composition. RESULTS: In lean and obese animals, regardless of muscle type, chronic muscle contraction improved muscle insulin sensitivity and increased intramuscular levels of total and most C14-C22 TAG fatty acids (p < 0.05). Therefore, accumulation in subcellular lipid droplet compartments reflected the oversupply of lipids within muscle. In contrast, improvements in insulin sensitivity induced by muscle contraction were associated with reductions in specific DAG and ceramide species that were not uniform in red and white muscle of obese rats. However, these reductions were insufficient to fully normalise insulin sensitivity, indicating that other mechanisms are involved. CONCLUSIONS/ INTERPRETATION: Reductions in 18 C length DAG and ceramide species were the most consistent in red and white muscle and therefore may represent therapeutic targets for improving insulin sensitivity.
AIMS/HYPOTHESIS: Although insulin resistance has been associated with accumulations of specific intramuscular fatty acids and altered subcellular localisation of lipid droplets, these concepts remain controversial. Therefore, we aimed to identify specific intramuscular fatty acids and subcellular lipid localisations associated with improved insulin sensitivity following chronic muscle contraction. METHODS: In lean and insulin-resistant obese Zucker rats the tibialis anterior muscle was stimulated (6 h/day for 6 days). Thereafter, muscles were examined for insulin sensitivity, intramuscular lipid droplet localisation and triacylglycerol (TAG), diacylglycerol (DAG) and ceramide fatty acid composition. RESULTS: In lean and obese animals, regardless of muscle type, chronic muscle contraction improved muscle insulin sensitivity and increased intramuscular levels of total and most C14-C22 TAGfatty acids (p < 0.05). Therefore, accumulation in subcellular lipid droplet compartments reflected the oversupply of lipids within muscle. In contrast, improvements in insulin sensitivity induced by muscle contraction were associated with reductions in specific DAG and ceramide species that were not uniform in red and white muscle of obeserats. However, these reductions were insufficient to fully normalise insulin sensitivity, indicating that other mechanisms are involved. CONCLUSIONS/ INTERPRETATION: Reductions in 18 C length DAG and ceramide species were the most consistent in red and white muscle and therefore may represent therapeutic targets for improving insulin sensitivity.
Authors: Carley R Benton; James G Nickerson; James Lally; Xiao-Xia Han; Graham P Holloway; Jan F C Glatz; Joost J F P Luiken; Terry E Graham; John J Heikkila; Arend Bonen Journal: J Biol Chem Date: 2007-12-12 Impact factor: 5.157
Authors: D A Pan; S Lillioja; A D Kriketos; M R Milner; L A Baur; C Bogardus; A B Jenkins; L H Storlien Journal: Diabetes Date: 1997-06 Impact factor: 9.461
Authors: Anneke M J van Hees; Anneke Jans; Gabby B Hul; Helen M Roche; Wim H M Saris; Ellen E Blaak Journal: Obesity (Silver Spring) Date: 2011-02-17 Impact factor: 5.002
Authors: Arend Bonen; Michelle L Parolin; Gregory R Steinberg; Jorge Calles-Escandon; Narendra N Tandon; Jan F C Glatz; Joost J F P Luiken; George J F Heigenhauser; David J Dyck Journal: FASEB J Date: 2004-05-07 Impact factor: 5.191
Authors: Hakam Alkhateeb; Adrian Chabowski; Jan F C Glatz; Joost F P Luiken; Arend Bonen Journal: Am J Physiol Endocrinol Metab Date: 2007-06-05 Impact factor: 4.310
Authors: John J Dubé; Francesca Amati; Maja Stefanovic-Racic; Frederico G S Toledo; Sarah E Sauers; Bret H Goodpaster Journal: Am J Physiol Endocrinol Metab Date: 2008-03-04 Impact factor: 4.310
Authors: Madeleen Bosma; Matthijs K C Hesselink; Lauren M Sparks; Silvie Timmers; Maria João Ferraz; Frits Mattijssen; Denis van Beurden; Gert Schaart; Marc H de Baets; Fons K Verheyen; Sander Kersten; Patrick Schrauwen Journal: Diabetes Date: 2012-07-17 Impact factor: 9.461
Authors: Leigh Perreault; Sean A Newsom; Allison Strauss; Anna Kerege; Darcy E Kahn; Kathleen A Harrison; Janet K Snell-Bergeon; Travis Nemkov; Angelo D'Alessandro; Matthew R Jackman; Paul S MacLean; Bryan C Bergman Journal: JCI Insight Date: 2018-02-08
Authors: Nicolas J Pillon; Scott Frendo-Cumbo; Maya R Jacobson; Zhi Liu; Paul L Milligan; Hai Hoang Bui; Juleen R Zierath; Philip J Bilan; Joseph T Brozinick; Amira Klip Journal: J Lipid Res Date: 2018-05-23 Impact factor: 5.922
Authors: Alison Ludzki; Sabina Paglialunga; Brennan K Smith; Eric A F Herbst; Mary K Allison; George J Heigenhauser; P Darrell Neufer; Graham P Holloway Journal: Diabetes Date: 2015-04-06 Impact factor: 9.461
Authors: Paul T Reidy; Ziad S Mahmassani; Alec I McKenzie; Jonathan J Petrocelli; Scott A Summers; Micah J Drummond Journal: Int J Mol Sci Date: 2020-02-22 Impact factor: 5.923